All In Biotech

Drug Trial Radar · NCT06007690

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 108 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

108

Actual

Start

Dec 6, 2023

Primary completion

Nov 15, 2027

Study completion Aug 15, 2028

Sponsor

Lead sponsor
Aura BiosciencesIndustry
Sponsor type
Industry
First posted
Aug 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma (CM).

Conditions

  • Choroidal Melanoma
  • Indeterminate Lesions
  • Uveal Melanoma
  • Ocular Melanoma

Interventions

  • Bel-sarDrug

    Bel-sar via suprachoroidal administration followed by laser application.

  • Suprachoroidal MicroinjectorDevice

    Suprachoroidal injection device

  • Infrared LaserDevice

    Laser application

  • Sham Infrared LaserDevice

    Sham laser application

  • Sham MicroinjectorDevice

    Sham injection device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to reach tumor progressionTime frame: 65 weeks

Locations

53 sites in 14 countries. Site status is shown where the registry gives one.

  • Doris Stein Eye Research Center

    Los Angeles, California

  • Stanford University School of Medicine

    Palo Alto, California

  • Retinal Consultants Medical Group, Inc.

    Sacramento, California

  • Emory Eye Center

    Atlanta, Georgia

  • University of Illinois at Chicago

    Chicago, Illinois

  • Tufts Medical Center New England Eye Center

    Boston, Massachusetts

  • Massachusetts Eye and Ear

    Boston, Massachusetts

  • W.K. Kellogg Eye Center - University of Michigan

    Ann Arbor, Michigan

  • Associated Retinal Consultants (ARC) P.C.

    Royal Oak, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • Columbia University Irving Medical Center

    New York, New York

  • Cole Eye Institute

    Cleveland, Ohio

  • Dean McGee Eye Institute

    Oklahoma City, Oklahoma

  • Retina Consultants of Oklahoma

    Oklahoma City, Oklahoma

  • Shields & Shields PC-Wills Eye Institute

    Philadelphia, Pennsylvania

  • Retina Consultants of Carolina

    Greenville, South Carolina

  • Tennessee Retina, PC

    Nashville, Tennessee

  • Austin Retina Associates

    Austin, Texas

  • Texas Retina Associates

    Dallas, Texas

  • Eye Cancer Associates of Texas

    Houston, Texas

  • Retina Center of Texas

    Southlake, Texas

  • Retina Associates of Utah

    Salt Lake City, Utah

  • Vitreoretinal Associates of Washington

    Bellevue, Washington

  • University of Washington Medical Center

    Seattle, Washington

  • University of Wisconsin Madison

    Madison, Wisconsin

  • Eye Research Australia

    East Melbourne, Victoria, Australia

  • Medical University Graz

    Graz, Austria

  • Medizinische Universität Wien, Department of Ophthalmology and Optometry

    Vienna, Austria

  • Cliniques universitaires Saint-Luc

    Brussels, Belgium

  • Serac Eye and Skin Care Centre

    Calgary, Alberta, Canada

  • Ustredni vojenska nemocnice Vojenska fakultni nemocnice Praha

    Prague, Czechia

  • Fakultni Thomayerova nemocnice

    Prague, Krč, Czechia

  • Fakultni nemocnice Plzen

    Pilsen, Plzenský Kraj, Czechia

  • Centre Hospitalier Universitaire de Nice

    Nice, Cedex 1, France

  • Hospices Civils de Lyon - Hôpital de La Croix Rousse - Hospital

    Lyon, Rhone, France

  • Charité - Universitätsmedizin Berlin KöR

    Berlin, Germany

  • Universitätsmedizin Essen

    Essen, Germany

  • Uniklinikum Hamburg Eppendorf

    Hamburg, Germany

  • Klinikum der LMU Muenchen

    München, Germany

  • The Chaim Sheba Medical Center

    Tel-Hashomer, Central District, Israel

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.